Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...

Light-intensity walking reduced postprandial glucose and diastolic blood pressure in young adults with obesity.

Patients with IBD don’t face an increased risk for major adverse cardiovascular events when taking Janus kinase inhibitors ...

Neoadjuvant immunotherapy offers a survival benefit in specific subtypes of patients but seems to offer no benefit in the ...

Intermittent calorie restriction followed for 2 nonconsecutive days per week reduced the liver fat content in patients with ...

The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in US patients hospitalized with heart failure (HF) and a left ...

Prioritizing wellness in nursing isn’t just essential for addressing the nationwide nursing shortage. Burnout in the medical ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...

Replacing animal-based protein sources with plant-based alternatives in older adults reduced both the quality and quantity of ...

The mineralocorticoid receptor antagonist did not reduce primary outcomes in the CLEAR SYNERGY trial, but there was a suggestion that it did prevent new or worsening heart failure.